Skip to main content

Table 2 Subjective assessment of presence of scar in the human subjects (Groups 1 and 2) and in the animals

From: Gray blood late gadolinium enhancement cardiovascular magnetic resonance for improved detection of myocardial scar

 

LV scara

Papillary muscle scara

 

GB-LGE

BB-LGE

Conventional LGEb

GB-LGE

BB-LGE

Conventional LGEb

Reader 1

 Group 1

9/18/0

9/17/1

6/19/2

14/13/0

12/15/0

10/17/0

 Group 2

8/10/0

n.a.

6/12/0

3/15/0

n.a.

3/15/0

 Animals

5/0/0

5/0/0

5/0/0

0/5/0

0/5/0

0/5/0

Reader 2

 Group 1

9/18/0

9/17/1

6/17/4

17/10/0

13/13/1

13/14/0

 Group 2

8/10/0

n.a.

7/11/0

3/15/0

n.a.

3/15/0

 Animals

5/0/0

5/0/0

5/0/0

0/5/0

0/5/0

0/5/0

  1. aData represent the number of cases scored as yes/no/uncertain regarding the presence of scar. Lack of BB-LGE data in group 2 is represented by ‘n.a.’ (i.e, not-available). GB gray blood, BB black blood, LGE late gadolinium enhancement
  2. bLGE (humans) or phase-sensitive LGE (animals)